BioCentury
ARTICLE | Company News

AstraZeneca, Merck & Co. Inc deal

March 3, 2008 8:00 AM UTC

AstraZeneca has an option to purchase Merck’s rights to those eight products in 2010 for about $650 million. If AstraZeneca exercises that option, the company will receive a second option to repurchas...